Mackenzie Financial Corp Buys 15,730 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Mackenzie Financial Corp boosted its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 123.2% during the second quarter, Holdings Channel.com reports. The firm owned 28,501 shares of the aerospace company’s stock after purchasing an additional 15,730 shares during the quarter. Mackenzie Financial Corp’s holdings in Leidos were worth $4,158,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Boston Partners boosted its position in Leidos by 5.8% during the first quarter. Boston Partners now owns 3,430,264 shares of the aerospace company’s stock valued at $449,592,000 after purchasing an additional 188,458 shares in the last quarter. Northern Trust Corp boosted its position in Leidos by 0.5% during the fourth quarter. Northern Trust Corp now owns 1,149,948 shares of the aerospace company’s stock valued at $124,470,000 after purchasing an additional 6,284 shares in the last quarter. Millennium Management LLC boosted its position in Leidos by 156.5% during the second quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after purchasing an additional 691,575 shares in the last quarter. Panagora Asset Management Inc. boosted its holdings in Leidos by 39.7% in the second quarter. Panagora Asset Management Inc. now owns 782,161 shares of the aerospace company’s stock worth $114,102,000 after acquiring an additional 222,179 shares in the last quarter. Finally, AQR Capital Management LLC boosted its holdings in Leidos by 76.9% in the second quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock worth $101,942,000 after acquiring an additional 303,775 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on LDOS shares. Royal Bank of Canada raised their price target on Leidos from $140.00 to $145.00 and gave the stock a “sector perform” rating in a report on Wednesday, July 31st. Bank of America raised their price target on Leidos from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Wells Fargo & Company raised their price target on Leidos from $172.00 to $183.00 and gave the stock an “overweight” rating in a report on Tuesday. Citigroup raised their price target on Leidos from $165.00 to $169.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Finally, Barclays raised their price target on Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Leidos currently has a consensus rating of “Moderate Buy” and an average price target of $164.00.

Insider Activity at Leidos

In related news, Director Robert C. Kovarik, Jr. sold 1,059 shares of Leidos stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $145.23, for a total transaction of $153,798.57. Following the completion of the transaction, the director now directly owns 7,455 shares in the company, valued at $1,082,689.65. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Leidos news, CEO Thomas Arthur Bell acquired 1,712 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was acquired at an average cost of $145.04 per share, for a total transaction of $248,308.48. Following the completion of the transaction, the chief executive officer now directly owns 22,398 shares of the company’s stock, valued at $3,248,605.92. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,059 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $145.23, for a total value of $153,798.57. Following the completion of the sale, the director now owns 7,455 shares of the company’s stock, valued at $1,082,689.65. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Leidos Stock Up 1.2 %

Shares of LDOS stock opened at $165.01 on Wednesday. The stock has a 50 day moving average of $152.51 and a 200 day moving average of $144.68. The company has a current ratio of 1.21, a quick ratio of 1.11 and a debt-to-equity ratio of 0.91. The stock has a market cap of $22.23 billion, a P/E ratio of 71.13, a P/E/G ratio of 1.43 and a beta of 0.70. Leidos Holdings, Inc. has a twelve month low of $89.22 and a twelve month high of $165.49.

Leidos (NYSE:LDOS) last announced its quarterly earnings results on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.36. The company had revenue of $4.13 billion during the quarter, compared to analysts’ expectations of $4.06 billion. Leidos had a return on equity of 28.40% and a net margin of 2.72%. Leidos’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the business earned $1.80 earnings per share. As a group, sell-side analysts expect that Leidos Holdings, Inc. will post 8.95 EPS for the current year.

Leidos Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 27th. Investors of record on Friday, September 13th were given a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 0.92%. The ex-dividend date was Friday, September 13th. Leidos’s dividend payout ratio is currently 65.52%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.